Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Albemarle Corporation (ALB) Guidance & Earnings Results

On 2026-08-05 Albemarle Corporation raised guidance: "FY2026 Specialties net sales raised to $1.4-1.6B from prior; Specialties adjusted EBITDA raised to $275-325M; capex reduced to…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ALBAlbemarle CorporationFollow ALB — free
Specialty Chemicals · Basic Materials
—
Price chart with a free account
Market cap
11.1B
P/E TTM
—
Dividend yield
1.7%
52-week
—
Next earnings
4 Nov, in 11 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
5 Aug 26RaisedFY2026 Specialties net sales raised to $1.4-1.6B from prior; Specialties adjusted EBITDA raised to $275-325M; capex reduced to ~$500M · full year
6 May 26RaisedIncreased full-year Specialties outlook for both sales and adjusted EBITDA; maintained enterprise outlook scenarios; capex forecast $550-600M unchanged · full year
11 Feb 26Raised2026 capex flat, meaningful FCF at higher lithium prices · full year
5 Nov 25RaisedEnterprise results expected towards higher end of previously published $9/kg scenario ranges · full year
30 Jul 25MixedFY2025 capex reduced to $650-$700M; maintaining prior outlook considerations based on $9/kg LCE scenario; expect positive free cash flow for FY2025 · full year

Albemarle Corporation — questions

What guidance did Albemarle Corporation give?
On 2026-08-05: "FY2026 Specialties net sales raised to $1.4-1.6B from prior; Specialties adjusted EBITDA raised to $275-325M; capex reduced to ~$500M"
When does Albemarle Corporation report earnings?
Albemarle Corporation's next earnings report is expected on 2026-11-04.

Every figure on this page comes from Albemarle Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.